BICYCLE THERAPEUTICS PLC - Common Stock (BCYC)

CUSIP: 088786108

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
49,984,905
Total 13F shares
41,735,285
Share change
-155,570
Total reported value
$354,350,748
Put/Call ratio
364%
Price per share
$8.49
Number of holders
95
Value change
-$8,366,393
Number of buys
42
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) as of Q1 2025

As of 31 Mar 2025, BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,735,285 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., FCPM III SERVICES B.V., ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Siren, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, Long Focus Capital Management, LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., and Candriam S.C.A.. This page lists 95 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.